These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 26005953)

  • 1. Newly developed apolipoprotein A-I mimetic peptide promotes macrophage reverse cholesterol transport in vivo.
    Shimizu T; Tanigawa H; Miura S; Kuwano T; Takata K; Suematsu Y; Imaizumi S; Yahiro E; Zhang B; Uehara Y; Saku K
    Int J Cardiol; 2015 Aug; 192():82-8. PubMed ID: 26005953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rosuvastatin activates ATP-binding cassette transporter A1-dependent efflux ex vivo and promotes reverse cholesterol transport in macrophage cells in mice fed a high-fat diet.
    Shimizu T; Miura S; Tanigawa H; Kuwano T; Zhang B; Uehara Y; Saku K
    Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2246-53. PubMed ID: 25104799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probucol-Oxidized Products, Spiroquinone and Diphenoquinone, Promote Reverse Cholesterol Transport in Mice.
    Yakushiji E; Ayaori M; Nishida T; Shiotani K; Takiguchi S; Nakaya K; Uto-Kondo H; Ogura M; Sasaki M; Yogo M; Komatsu T; Lu R; Yokoyama S; Ikewaki K
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):591-7. PubMed ID: 26848156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic Overexpression of Endothelial Lipase Lowers High-Density Lipoprotein but Maintains Reverse Cholesterol Transport in Mice: Role of Scavenger Receptor Class B Type I/ATP-Binding Cassette Transporter A1-Dependent Pathways.
    Takiguchi S; Ayaori M; Yakushiji E; Nishida T; Nakaya K; Sasaki M; Iizuka M; Uto-Kondo H; Terao Y; Yogo M; Komatsu T; Ogura M; Ikewaki K
    Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1454-1467. PubMed ID: 29748333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-atherosclerotic effects of an improved apolipoprotein A-I mimetic peptide.
    Suematsu Y; Kawachi E; Idemoto Y; Matsuo Y; Kuwano T; Kitajima K; Imaizumi S; Kawamura A; Saku K; Uehara Y; Miura SI
    Int J Cardiol; 2019 Dec; 297():111-117. PubMed ID: 31519377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteasomal inhibition promotes ATP-binding cassette transporter A1 (ABCA1) and ABCG1 expression and cholesterol efflux from macrophages in vitro and in vivo.
    Ogura M; Ayaori M; Terao Y; Hisada T; Iizuka M; Takiguchi S; Uto-Kondo H; Yakushiji E; Nakaya K; Sasaki M; Komatsu T; Ozasa H; Ohsuzu F; Ikewaki K
    Arterioscler Thromb Vasc Biol; 2011 Sep; 31(9):1980-7. PubMed ID: 21817095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lecithin: cholesterol acyltransferase expression has minimal effects on macrophage reverse cholesterol transport in vivo.
    Tanigawa H; Billheimer JT; Tohyama J; Fuki IV; Ng DS; Rothblat GH; Rader DJ
    Circulation; 2009 Jul; 120(2):160-9. PubMed ID: 19564558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LAL (Lysosomal Acid Lipase) Promotes Reverse Cholesterol Transport In Vitro and In Vivo.
    Bowden KL; Dubland JA; Chan T; Xu YH; Grabowski GA; Du H; Francis GA
    Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1191-1201. PubMed ID: 29599133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FAMP, a novel apoA-I mimetic peptide, suppresses aortic plaque formation through promotion of biological HDL function in ApoE-deficient mice.
    Uehara Y; Ando S; Yahiro E; Oniki K; Ayaori M; Abe S; Kawachi E; Zhang B; Shioi S; Tanigawa H; Imaizumi S; Miura S; Saku K
    J Am Heart Assoc; 2013 May; 2(3):e000048. PubMed ID: 23709562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage reverse cholesterol transport in mice expressing ApoA-I Milano.
    Alexander ET; Weibel GL; Joshi MR; Vedhachalam C; de la Llera-Moya M; Rothblat GH; Phillips MC; Rader DJ
    Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1496-501. PubMed ID: 19661486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrogen Activates ATP-Binding Cassette Transporter A1-Dependent Efflux Ex Vivo and Improves High-Density Lipoprotein Function in Patients With Hypercholesterolemia: A Double-Blinded, Randomized, and Placebo-Controlled Trial.
    Song G; Lin Q; Zhao H; Liu M; Ye F; Sun Y; Yu Y; Guo S; Jiao P; Wu Y; Ding G; Xiao Q; Qin S
    J Clin Endocrinol Metab; 2015 Jul; 100(7):2724-33. PubMed ID: 25978109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct evidence in vivo of impaired macrophage-specific reverse cholesterol transport in ATP-binding cassette transporter A1-deficient mice.
    Calpe-Berdiel L; Rotllan N; Palomer X; Ribas V; Blanco-Vaca F; Escolà-Gil JC
    Biochim Biophys Acta; 2005 Dec; 1738(1-3):6-9. PubMed ID: 16413225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo reverse cholesterol transport from macrophages lacking ABCA1 expression is impaired.
    Wang MD; Franklin V; Marcel YL
    Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1837-42. PubMed ID: 17541020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of ABCA1 protein degradation promotes HDL cholesterol efflux capacity and RCT and reduces atherosclerosis in mice.
    Huang L; Fan B; Ma A; Shaul PW; Zhu H
    J Lipid Res; 2015 May; 56(5):986-97. PubMed ID: 25761370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Density Lipoprotein Mimetics: a Therapeutic Tool for Atherosclerotic Diseases.
    Ikenaga M; Higaki Y; Saku K; Uehara Y
    J Atheroscler Thromb; 2016; 23(4):385-94. PubMed ID: 26830201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ApoE promotes hepatic selective uptake but not RCT due to increased ABCA1-mediated cholesterol efflux to plasma.
    Annema W; Dikkers A; Freark de Boer J; Gautier T; Rensen PCN; Rader DJ; Tietge UJF
    J Lipid Res; 2012 May; 53(5):929-940. PubMed ID: 22383685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-Density Lipoprotein-Targeted Therapy and Apolipoprotein A-I Mimetic Peptides.
    Uehara Y; Chiesa G; Saku K
    Circ J; 2015; 79(12):2523-8. PubMed ID: 26548857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quercetin improves macrophage reverse cholesterol transport in apolipoprotein E-deficient mice fed a high-fat diet.
    Cui Y; Hou P; Li F; Liu Q; Qin S; Zhou G; Xu X; Si Y; Guo S
    Lipids Health Dis; 2017 Jan; 16(1):9. PubMed ID: 28088205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevation of systemic PLTP, but not macrophage-PLTP, impairs macrophage reverse cholesterol transport in transgenic mice.
    Samyn H; Moerland M; van Gent T; van Haperen R; Grosveld F; van Tol A; de Crom R
    Atherosclerosis; 2009 Jun; 204(2):429-34. PubMed ID: 19100548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted Deletion of Hepatocyte Abca1 Increases Plasma HDL (High-Density Lipoprotein) Reverse Cholesterol Transport via the LDL (Low-Density Lipoprotein) Receptor.
    Bashore AC; Liu M; Key CC; Boudyguina E; Wang X; Carroll CM; Sawyer JK; Mullick AE; Lee RG; Macauley SL; Parks JS
    Arterioscler Thromb Vasc Biol; 2019 Sep; 39(9):1747-1761. PubMed ID: 31167565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.